Our success is built on diverse corporate management and financial industry experience.
Our directors have a combined wealth of leadership experience derived from extensive service guiding large, complex organizations as executive leaders or board members, and in government and academia. They collectively have substantive knowledge
and skills applicable to our business, including in the areas of regulation, public accounting and financial reporting, finance, risk management, business development, technology, marketing, operations, strategic planning, management development
and succession, compensation, corporate governance, public policy, international matters, banking and financial services.
Thomas G. Maheras was appointed independent chairman in May 2020, following his service as director starting in 2008. He has been the managing partner of Tegean Capital Management, LLC since 2008, and a partner of Iron Park Capital Management, LLC since 2019, two investment advisory firms based in New York. Prior to that, he was chairman and co-chief executive officer of Citi Markets and Banking, the investment banking division of Citigroup, Inc. He has served as chairman of the U.S. Treasury Department Borrowing Advisory Committee and as an executive committee member of the Board of Directors of the Securities Industry and Financial Markets Association.
Jeffrey S. Aronin
Director - Compensation and Leadership Development Committee
Jeffrey S. Aronin has been chairman and chief executive officer of Paragon Pharmaceutical Capital, LLC since 2010. He is also chairman and chief executive officer of Paragon Biosciences, LLC, an affiliated global life science innovation and investment firm. Currently, he is the chairman of several of Paragon’s portfolio companies, including Harmony Biosciences Holdings, Inc. From 2010 to 2017, Mr. Aronin was also chairman and chief executive officer of Marathon Pharmaceuticals, a research-based prescription biopharmaceutical company. From 2000 to 2009, he was president and chief executive officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000. In 2009, Ovation Pharmaceuticals was acquired by Lundbeck, Inc. Mr. Aronin served as president and chief executive officer of Lundbeck, Inc. during its acquisition and integration of Ovation Pharmaceuticals.
Mary K. Bush
Director - Nominating and Governance Committee (Chair), Risk Oversight Committee
Mary K. Bush has served as the chairman of Bush International, LLC, a financial and business strategy advisory firm, since 1991. Ms. Bush was the inaugural head and managing director of the Federal Housing Finance Board, where she established financial policies and oversaw management and safety and soundness for the nation’s Federal Home Loan Banks. She served as vice president and head of International Finance of Fannie Mae and as the U.S. Alternate Executive Director of the International Monetary Fund Board. In 2007, she served on the U.S. Department of the Treasury's Advisory Commission on the Auditing Profession. Ms. Bush is a member of the board of directors of ManTech International Corporation, T. Rowe Price Group, Inc., and Bloom Energy. Ms. Bush served on the board of Marriott International, Inc. from 2008 to 2020.
Gregory C. Case
Director - Compensation and Leadership Development Committee (Chair)
Gregory C. Case has been chief executive officer of Aon plc, a leading global professional services firm providing advice and solutions in risk, retirement and health, since 2005 and was president from 2005 to 2018. He is also a member of Aon's board of directors. Prior to joining Aon, Mr. Case was with McKinsey & Company, an international management consulting firm, for 17 years, most recently serving as head of the Financial Services Practice. Prior to joining McKinsey, he worked for the investment banking firm of Piper, Jaffray and Hopwood and the Federal Reserve Bank in Kansas City.
Candace H. Duncan
Director - Audit Committee, Nominating and Governance Committee
Ms. Duncan retired from KPMG LLP, a global network of professional firms providing audit, tax and advisory services, in November 2013 where she had been managing partner of the Washington, D.C. metropolitan area since 2009. Ms. Duncan also was on the KPMG LLP board of directors from 2009 to 2013, and served as chair of the board's nominating committee as well as the partnership and employer of choice committee. Prior to that, she served in various roles at the firm, including managing partner for audit for the Midatlantic area and audit partner in charge for the Virginia business unit. Ms. Duncan was admitted to the KPMG LLP partnership in 1987 and had more than 35 years of experience as a professional with the firm. Ms. Duncan is a member of the board of directors of Teleflex Inc. and served on the board of FTD Companies, Inc. from 2014 to 2019.
Joseph F. Eazor
Director - Audit Committee
Joseph F. Eazor is the president and chief executive officer of ERT, a global data and technology company that helps minimize risk in clinical trials. Prior to assuming this role in October 2020, he served as president and chief executive officer of Conifer Health Solutions, a healthcare business solutions organization, from January - August 2020. Mr. Eazor was executive vice president and chief customer officer of computer software company Oracle Corporation, from July 2019 to January 2020, and chief executive officer of Rackspace, a leading managed cloud company, from 2017 to 2019. Mr. Eazor previously served as the president and chief executive officer of EarthLink, Inc., a leading communications and IT services provider, and was a member of EarthLink’s board from January 2014 until February 2017. From 2011 to 2013, he served as executive vice president and chief operating officer of global sales and customer operations at EMC and prior to that he served in a variety of leadership roles at Hewlett Packard and Electronic Data Systems. Mr. Eazor also served on the board of Commvault, a data protection and information management company, from 2015 to 2018.
Cynthia A. Glassman
Director - Audit Committee (Chair)
Dr. Cynthia A. Glassman was appointed by President Bush as Under Secretary for Economic Affairs at the U.S. Department of Commerce from 2006 to 2009 and as Commissioner of the U.S. Securities and Exchange Commission from 2002 to 2006, including serving as Acting Chair during the summer of 2005. Dr. Glassman is a Senior Research Scholar at the Institute for Corporate Responsibility at the George Washington University School of Business and a member of the Dow Jones Special Committee. She held various positions during her 12 years at the Federal Reserve, including as Chief of the Financial Reports Section and an Economist in the Capital Markets Section. Dr. Glassman served on the board of Navigant Consulting, Inc. from 2009 to 2019.
Roger C. Hochschild
Roger C. Hochschild, chief executive officer and president of Discover, was elected to the board in August 2018. Mr. Hochschild was president and chief operating officer of Discover from 2004 to 2018. He was executive vice president, chief administrative and strategic officer for Morgan Stanley from 2001 to 2004, and was executive vice president, chief marketing officer - Discover from 1998 to 2001, when Discover was a part of Morgan Stanley. Mr. Hochschild is also on the board of directors of Principal Financial Group.
Michael H. Moskow
Director - Risk Oversight Committee (Chair)
Michael H. Moskow is currently Vice Chair and Distinguished Fellow, Global Economy at The Chicago Council on Global Affairs. He retired as president and chief executive officer of the Federal Reserve Bank of Chicago in 2007, where he had served since 1994. Mr. Moskow was a Deputy U.S. Trade Representative, following his appointment by President Bush in 1991, and earlier in his career, he held a number of senior positions with the U.S. government, including undersecretary of labor at the U.S. Department of Labor, director of the Council on Wage and Price Stability and senior staff economist with the Council of Economic Advisers. Mr. Moskow serves on the board of directors of Flowstone Private Equity Opportunity Fund and served on the board of Commonwealth Edison Company, a subsidiary of Exelon Corporation, from 2008 to 2021.
David L. Rawlinson
Director - Audit Committee
David L. Rawlinson will serve as President and Chief Executive Officer-Elect of Qurate Retail, Inc. (“QRI”) effective August 1, 2021, and effective October 1, 2021, Mr. Rawlinson will serve as President and Chief Executive Officer of QRI. Previously, Mr. Rawlinson was the Chief Executive Officer of NielsenIQ (formerly Nielsen Global Connect), a global data and measurement company, from February 2020 to March 2021. From November 2015 until joining Nielsen’s management, he served as President of the Global Online Business at W.W. Grainger, Inc. Mr. Rawlinson joined Grainger in July 2012 and previously served as the Vice President of Operations for the Global Online Business, and prior to that, Vice President, Deputy General Counsel and Corporate Secretary of Grainger. Mr. Rawlinson worked for ITT Exelis (formerly ITT Corp.) from 2009 to 2012, most recently as Vice President, General Counsel and Director of Corporate Responsibility of the Electronic Systems division. Prior to that, he served as a White House Fellow and held appointed positions in both the George W. Bush and Obama Administrations. Mr. Rawlinson served on the board of MonotaRO Co., Ltd. from 2014 to 2019 and the board of Nielsen Holdings plc from 2017 to 2021.
Mark A. Thierer
Director - Compensation and Leadership Development Committee, Nominating and Governance Committee
Mark A. Thierer is managing partner of AssetBlue Investment Group, a position he has held since 2017. From October 2017 through February 2018, Mr. Thierer also served as the interim chief executive officer of Dentsply Sirona Inc., a manufacturer of dental implants. He was chief executive officer of OptumRx, a pharmacy care services company, from 2015 to 2017. Mr. Thierer previously served as chairman and chief executive officer of Catamaran Corporation, one of the nation's largest pharmacy benefit management companies, from March 2011 until it combined with OptumRx in 2015. Mr. Thierer is a member of the board of directors of Xeris Pharmaceuticals, Inc. and Senior Connect Acquisition Corp.
Jennifer L. Wong
Director – Risk Oversight Committee
Jennifer L. Wong has been the chief operating officer of Reddit, Inc., a community and discussion platform, since 2018, where she oversees business strategy and growth, and related teams for the company. She previously served as Time, Inc.’s president of digital and then its chief operating officer from 2016 to 2018, where she led growth strategy and digital business transformation. Prior to that, Ms. Wong held the role of chief business officer from 2011 to 2015 at Popsugar, Inc., a media and technology company, where she led business operations and the company's media and commerce businesses. Earlier in her career, Ms. Wong held several executive management roles at AOL and worked with a range of digital media and technology clients at McKinsey & Company. Ms. Wong is a member of the board of directors of Group Nine Acquisition Corp.